As we are representing numerous individuals in the GranuFlo recall litigation underway in Massachusetts, we are not surprised to see its case list continuing to increase.
New York, NY (PRWEB) December 31, 2014
Nearly 3,000 GranuFlo lawsuits (http://www.granuflolawsuit2014.com/) are now pending in the District of Massachusetts, where a federal litigation continues to move forward more than two years after the dialysis drug recall, Bernstein Liebhard LLP reports.
Federal court documents updated on December 15th show 2,289 claims filed in the U.S. District Court, District of Massachusetts on behalf of individuals who were allegedly injured by this medication, or NaturaLyte, a similar product. Plaintiffs in these cases claim to have suffered sudden cardiac death, cardiopulmonary arrest, heart attacks, strokes and other life-threatening heart injuries, which they allege the drug’s manufacturer, Fresenius Medical Care, failed to properly warn about. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)
“As we are representing numerous individuals in the GranuFlo recall litigation underway in Massachusetts, we are not surprised to see its case list continuing to increase,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently evaluating GranuFlo and NaturaLyte lawsuits on behalf of individuals who were allegedly injured by the dialysis medications.
All the GranuFlo and NaturaLyte lawsuits now pending in the District of Massachusetts allege life-threatening cardiovascular injuries caused by the dialysis medications, which were subject to a Class I recall in June 2012 by the U.S. Food and Drug Administration (FDA). This federal action was taken two months after Fresenius issued an Urgent Product Notification that warned about the potential for its products to cause metabolic alkalosis, a condition that stems from elevated levels of bicarbonate in the body and has been associated with serious cardiovascular problems. According to the FDA’s recall notice, GranuFlo and NaturaLyte side effects may be serious, and potentially fatal.
Thousands of dialysis lawsuits have been filed since then, both in the GranuFlo litigation underway in Massachusetts, where Bernstein Liebhard LLP is actively filing claims, and in a consolidated proceeding established in Middlesex County Superior Court. There, court documents show 3,900 dialysis suits centralized in December. (In re: Consolidated Fresenius Cases, No. MICV2013-03400-O).
Dialysis patients who experienced life-threatening cardiovascular events that were allegedly caused by GranuFlo or NaturaLyte may be entitled to join this growing litigation. To learn more about filing a GranuFlo lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For additional information, and to arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP